Dolan Oliver

Reported to SECin USFilings at 1 company

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 4 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

4
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
Korro Bio, Inc.Senior Vice President, FinanceOpen-market sell$695 sharesSep 14, 2026Korro Bio, Inc.Senior Vice President, Finance$69Sell · Sep 14Open-market sell5Sep 14, 2026
Korro Bio, Inc.Senior Vice President, FinanceOpen-market sell$826 sharesSep 10, 2026Korro Bio, Inc.Senior Vice President, Finance$82Sell · Sep 10Open-market sell6Sep 10, 2026
Korro Bio, Inc.Senior Vice President, FinanceOpen-market sell$99,2867,347 sharesSep 10, 2026Korro Bio, Inc.Senior Vice President, Finance$99,286Sell · Sep 10Open-market sell7,347Sep 10, 2026
Korro Bio, Inc.Senior Vice President, FinanceAwardnothing paid5,500 sharesJul 17, 2026Korro Bio, Inc.Senior Vice President, Financenothing paidAward · Jul 17Award5,500Jul 17, 2026